This past Wednesday was Stem Cell Awareness Day, a day that is meant to remind us all of the importance of stem cell research and the potential it has to treat a wide variety of diseases. On this day, we also released an independent Economic Impact Report that showed how $10.7 Billion (yes, you read … Continue reading Encouraging Progress for Two CIRM Supported Clinical Trials
Author: Yimy Villa
Rare Disease, Type 1 Diabetes, and Heart Function: Breakthroughs for Three CIRM-Funded Studies
This past week, there has been a lot of mention of CIRM funded studies that really highlight the importance of the work we support and the different disease areas we make an impact on. This includes important research related to rare disease, Type 1 Diabetes (T1D), and heart function. Below is a summary of the … Continue reading Rare Disease, Type 1 Diabetes, and Heart Function: Breakthroughs for Three CIRM-Funded Studies
CIRM-funded Stanford study finds potential diagnostic tool, treatment for Parkinson’s
Dr. Xinnan Wang, a neurosurgeon and author of a study that has identified a molecular pathway apparently responsible for the death of dopaminergic neurons that causes the symptoms of Parkinson's. Of the various neurodegenerative diseases, Parkinson's is the second most common and affects 35 million people world wide. It is caused by the gradual breakdown of … Continue reading CIRM-funded Stanford study finds potential diagnostic tool, treatment for Parkinson’s
Engineered T cells made from stem cells could provide immunity against multiple cancers
Dr. Lily Yang Within all of our bodies there is a special type of "super" immune cell that holds enormous potential. Unlike regular immune cells that can only attack one cancer at a time, these "super" immune cells have the ability to target many types of cancers at once. These specialized cells are known as … Continue reading Engineered T cells made from stem cells could provide immunity against multiple cancers
California Stem Cell and Regenerative Therapy Task Force holds meeting to consider options for patient protection
Dr. Maria Millan, President and CEO of CIRM, attended the meeting to discuss the importance of having systems in place for patient protection. What procedures are in place to ensure the quality and safety of stem cell treatments? How can patients guard against deceptive promotional practices for treatments that have no basis in science? What … Continue reading California Stem Cell and Regenerative Therapy Task Force holds meeting to consider options for patient protection
Scientists at USC untangle the mysteries of cellular reprogramming- a method that could be used to treat diseases
Dr. Justin Ichida, Assistant Professor at USC and lead author of the study Scientists have long tried to repurpose cells in order to potentially treat various types of conditions. This process, called reprogramming, involves changing one type of cell into another, such as a blood cell into a muscle cell or nerve cell. Although the … Continue reading Scientists at USC untangle the mysteries of cellular reprogramming- a method that could be used to treat diseases
Stem cell treatment restores man’s sight in right eye after 25 years
James O'Brien, recipient of a stem cell treatment that restored the vision in his right eye At 18 years old, there are several life-changing moments that young people look forward to. For some, it involves graduating from high school, starting college, and being able to cast a vote in an election. For others, this momentous … Continue reading Stem cell treatment restores man’s sight in right eye after 25 years
Rare disease meeting at California Capitol stresses importance of advocacy, funding, and new research
Dr. Martin Cadeiras (far left), who specializes in cardiovascular medicine at UC Davis, discusses the rare disease amyloidosis. Next to Dr. Cadeiras is Len Strickland, a patient advocates who shares his perspective on living with the disease. "By changing policy, we can change lives" A powerful opening statement by Angela Ramirez Holmes, Founder & President … Continue reading Rare disease meeting at California Capitol stresses importance of advocacy, funding, and new research
CIRM board member Lauren Miller Rogen appointed to California Alzheimer’s Task Force
Lauren Miller Rogen, Hilarity for Charity co-founder and CIRM Board Member California has the largest aging population in the United States. The U.S. Census Bureau has estimated that one in five Californians will be 65 or older by the year 2030. Unfortunately with age comes a wide of health related issues that can arise such … Continue reading CIRM board member Lauren Miller Rogen appointed to California Alzheimer’s Task Force
Drug used to treat multiple sclerosis may improve glioblastoma outcomes
Dr. Jeremy Rich, UC San Diego Glioblastoma is an aggressive form of cancer that invades brain tissue, making it extremely difficult to treat. Current therapies involving radiation and chemotherapy are effective in destroying the bulk of brain cancer cells, but they are not able to reach the brain cancer stem cells, which have the ability … Continue reading Drug used to treat multiple sclerosis may improve glioblastoma outcomes
The Stem Cellar 